TESSERA THERAPEUTICS, INC

Award ID:140D042590015Agreement Type:Prototype

Base & Exercised Options

$11.9M

Total value for base award plus exercised options.

Period End Date

Sep 22, 2031

Ultimate completion date for this OTA.

Agreement Type

Prototype

Prototype, production, or follow-on production agreement type.

Overview

Awardee

TESSERA THERAPEUTICS, INC

UEI: XFPJKGA6ARL1

Awarding Agency

DEPARTMENTAL OFFICES

Code: 1406

Funding Agency

NATIONAL INSTITUTES OF HEALTH

Code: 7529

Extent Competed

Competitive Delivery Order - Fair Opportunity Provided

Consortia

No - Not a Consortia Member

PSC Code

AN13